Tucatinib 150mg Tablets are an advanced targeted therapy widely used in the treatment of HER2-positive breast cancer, especially in patients with advanced or metastatic conditions. As a highly selective HER2 inhibitor, Tucatinib helps slow down the growth and spread of cancer cells while improving treatment outcomes when combined with other therapies.
Cordium Pharmaceuticals Pvt Ltd, a leading global exporter based in India, ensures a reliable supply of high-quality Tucatinib 150mg Tablets with fast and secure delivery to major international markets including the United States, Germany, United Kingdom, Netherlands, South Africa, United Arab Emirates, and Brazil.
Key Uses of Tucatinib 150mg Tablets
Treatment of HER2-positive metastatic breast cancer
Used in combination with trastuzumab and capecitabine
Helps control tumor progression and improve survival rates
Suitable for patients who have received prior anti-HER2 therapies
Dosage & Administration
Standard dosage: As prescribed by a qualified healthcare professional
Typically taken orally, twice daily with or without food
Must be used in combination therapy for optimal effectiveness
Do not alter dosage without medical advice
Note: Always follow your doctor’s prescription and guidelines strictly.
Possible Side Effects
Diarrhea
Fatigue
Nausea and vomiting
Liver enzyme abnormalities
Decreased appetite
Hand-foot syndrome (when used with capecitabine)
If any severe or persistent side effects occur, immediate medical consultation is advised.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Trusted global exporter of oncology medicines
Assured quality and compliance with international standards
Fast and reliable delivery worldwide
Competitive pricing for bulk and retail orders
Dedicated customer support
Global Export & Fast Delivery Locations
We provide quick shipping to:
United States
Germany
United Kingdom
Netherlands
South Africa
United Arab Emirates
Brazil
Contact for Bulk Orders & Enquiries
📞 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
